Meet the Proteona team at the Phar-East Conference in Singapore
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications
Proteona announced that Dr Andreas Schmidt, Proteona Chief Executive Officer, will present at the Phar-East conference in Singapore at 14:40pm on the 20th March, 2019.
Dr Schmidt will share on the latest updates on Proteona and will be available during the conference for discussions.
For media queries, please contact:
Dr Andreas Schmidt
Proteona Pte. Ltd. is a new biomedical company based in Singapore, Germany, and the US that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.